Publication | Open Access
VX765 Attenuates Pyroptosis and HMGB1/TLR4/NF-<i>κ</i>B Pathways to Improve Functional Outcomes in TBI Mice
104
Citations
58
References
2020
Year
In conclusion, VX765 can counteract neurological damage after TBI by reducing pyroptosis and HMGB1/TLR4/NF-<i>κ</i>B pathway activities. VX765 may have a good therapeutic effect on TBI.
| Year | Citations | |
|---|---|---|
Page 1
Page 1